Report Details:
15 Companies Covered
128 Pages
Market Highlights
The Gene Sequencing Market Size was valued at USD 24.7 Billion in 2024 and the market is projected to grow from USD 30.13 Billion in 2025 to USD 220.13 Billion by 2035, registering a CAGR of 22% during the forecast period (2025–2035).
One of the primary factors driving the growth of the gene sequencing industry is the increasing prevalence of genetic illnesses. Over the past few years, there has been a significant increase in the number of people suffering from diseases like cancer, Alzheimer's disease, and cystic fibrosis.
As a result, there is a growing need for effective and precise gene sequencing techniques to support diagnostic and treatment protocols. Additionally, the market for gene sequencing is expanding more quickly due to patients' and healthcare providers' growing inclination for individualized medicine.
MRFR recognizes the following companies as the key players in the global gene sequencing market - Intrexon Bioinformatics Germany GmbH, QIAGEN, Myriad Genetics, Eurofins Scientific, PierianDx, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Pacific Biosciences of California, Inc., and Illumina, Inc.
Segment Analysis
The global gene sequencing market has been segmented into product type, application, workflow, and end user.
On the basis of product type, the market is segmented into Consumables, Instruments, and Services. The consumables segment was attributed to holding the largest market share in 2024.
The expanding need for DNA sequencing services and the rising uptake of next-generation sequencing technologies fuel the segment's rise. Segmental expansion is also aided by the increasing use of consumables in DNA sequencing operations.
Based on application, the global gene sequencing market has been segmented into Oncology, Reproductive Health, Clinical Investigation, Consumer Genomics, Metagenomics, and Others. The oncology segment was expected to hold the largest market share in 2024.
The growing oncology market is primarily driven by the growing use of DNA sequencing for cancer diagnosis, treatment selection, and response tracking. Furthermore, the global cancer patient population is expanding, and healthcare practitioners are becoming more knowledgeable about DNA sequencing technology, accelerating the growth pace of this market.
Based on workflow, the global gene sequencing market has been segmented into Pre-Sequencing, Sequencing, and Data Analysis. The sequencing segment was expected to hold the largest market share in 2024. The category is growing mostly due to the increasing number of uses for gene sequencing, including drug discovery and precision medicine.
Based on end user, the global gene sequencing market has been segmented into Academic Research, Clinical Research, Hospitals, Pharmaceutical Companies, and Others. The academic research segment was expected to hold the largest market share in 2024.
The US, UK, Germany, France, China, and several research institutes and standalone genomic laboratories are mostly responsible for the widespread use of genome sequencing technologies. These centers carry out large-scale studies on the sequence structural levels of genomics in order to create personalized and effective novel treatments.
Regional Analysis
The global gene sequencing market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe gene sequencing market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe.
The gene sequencing market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World gene sequencing market comprises the Middle East, Africa, and Latin America.
The largest market share for gene sequencing was maintained by the North American regional sector. The main revenue-generating nations in the North American region are the US and Canada. North America's sophisticated healthcare system and growing patient awareness would probably lead to growth in the genome sequencing market.
Furthermore, since the introduction of NGS, there has been an increase in the need for individualized medication. Personalized treatment avoids damaging healthy body parts by targeting just sick cells. There are fewer adverse consequences to go along with this improved efficiency.
Moreover, the Europe market has been persistently growing over the forecast period because of rising R&D expenditures and ongoing scientific research, which has increased demand for cutting-edge NGS technologies. For instance, in March 2020, a group of Italian researchers examined the SARS-CoV-2 genome from specimens obtained locally using Thermo Fisher Scientific's NGS research assay, and their findings indicated that the genome of the fast-spreading virus is stable.
Additionally, Asia Pacific is anticipated to experience the quickest growth over the forecast period. The government initiatives of developing countries to establish a genetic database are expected to cause the expansion because of the vast population in this region. Later on, preventative and preventive medicine will make use of this database.
For instance, the CSIR Institute of Genomics and Integrative Biology (IGIB) is leading the Genomics for Public Health in India (IndigenGen) project, launched in March 2020. In the coming years, 20,000 Indians are expected to be enrolled for whole genome sequencing to expand the database.
Furthermore, the rest of the world's gene sequencing market is divided into the Middle East, Africa, and Latin America. With more product releases and approvals anticipated in the next years, the rest of the world will probably be an important market for genome sequencing. The growing incidence of uncommon diseases, the aging population, and the increase in cancer patients in the area have led to a need for more specialized drugs, such as genome sequencing-based tailored medicines.
Key Findings of the Study
- Technological advancements in sequencing methods are enhancing accuracy and efficiency, thereby expanding market potential.
- North America remains the largest market for gene sequencing, while Asia-Pacific is emerging as the fastest-growing region.
- Next Generation Sequencing dominates the market, whereas Sanger Sequencing is witnessing rapid growth due to its specific applications.
- Rising demand for genetic testing and increased investment in genomic research are key drivers propelling market expansion.
